EP1809612A4 - Analogues de dibenzodiazepinone, et leurs procedes de production et d'utilisation comme substances pharmaceutiques - Google Patents

Analogues de dibenzodiazepinone, et leurs procedes de production et d'utilisation comme substances pharmaceutiques

Info

Publication number
EP1809612A4
EP1809612A4 EP05791575A EP05791575A EP1809612A4 EP 1809612 A4 EP1809612 A4 EP 1809612A4 EP 05791575 A EP05791575 A EP 05791575A EP 05791575 A EP05791575 A EP 05791575A EP 1809612 A4 EP1809612 A4 EP 1809612A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceuticals
processes
production
dibenzodiazepinone analogues
dibenzodiazepinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05791575A
Other languages
German (de)
English (en)
Other versions
EP1809612A1 (fr
Inventor
James B Mcalpine
Arjun H Banskota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thallion Pharmaceuticals Inc
Original Assignee
Thallion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/951,436 external-priority patent/US7186713B2/en
Priority claimed from CA 2497031 external-priority patent/CA2497031A1/fr
Application filed by Thallion Pharmaceuticals Inc filed Critical Thallion Pharmaceuticals Inc
Publication of EP1809612A1 publication Critical patent/EP1809612A1/fr
Publication of EP1809612A4 publication Critical patent/EP1809612A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP05791575A 2004-09-27 2005-09-26 Analogues de dibenzodiazepinone, et leurs procedes de production et d'utilisation comme substances pharmaceutiques Withdrawn EP1809612A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/951,436 US7186713B2 (en) 2003-01-21 2004-09-27 Farnesyl dibenzodiazepinones and methods of treating cancer using same
US62565304P 2004-11-08 2004-11-08
US64738105P 2005-01-28 2005-01-28
CA 2497031 CA2497031A1 (fr) 2004-11-08 2005-02-11 Farnesyldibenzodiazepinones, procedes de production et utilisation comme medicaments
US70147205P 2005-07-22 2005-07-22
PCT/CA2005/001467 WO2006034574A1 (fr) 2004-09-27 2005-09-26 Analogues de dibenzodiazepinone, et leurs procedes de production et d'utilisation comme substances pharmaceutiques

Publications (2)

Publication Number Publication Date
EP1809612A1 EP1809612A1 (fr) 2007-07-25
EP1809612A4 true EP1809612A4 (fr) 2009-05-27

Family

ID=36118533

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05791575A Withdrawn EP1809612A4 (fr) 2004-09-27 2005-09-26 Analogues de dibenzodiazepinone, et leurs procedes de production et d'utilisation comme substances pharmaceutiques

Country Status (4)

Country Link
EP (1) EP1809612A4 (fr)
JP (1) JP2008514551A (fr)
AU (1) AU2005289317A1 (fr)
WO (1) WO2006034574A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007015171A (es) * 2005-06-02 2008-04-22 Thallion Pharmaceuticals Inc Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable.
US20090170837A1 (en) * 2007-08-17 2009-07-02 Thallion Pharmaceuticals Inc. Methods for treating ras driven cancer in a subject
JP5068209B2 (ja) * 2008-03-27 2012-11-07 学校法人金城学院 高速向流クロマトグラフィーによるターメリックパウダー（ウコン粉末）からのクルクミン類の分離精製法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128288A1 (fr) * 2005-06-02 2006-12-07 Thallion Pharmaceuticals Inc. Formulation comprenant de la farnesyle dibenzodiazepinone et tensioactif acceptable sur le plan pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541181A (en) * 1994-05-26 1996-07-30 Bristol-Myers Squibb Company Compound produced by a strain of micromonospora
NZ561169A (en) * 2003-01-21 2008-06-30 Thallion Pharmaceuticals Inc Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128288A1 (fr) * 2005-06-02 2006-12-07 Thallion Pharmaceuticals Inc. Formulation comprenant de la farnesyle dibenzodiazepinone et tensioactif acceptable sur le plan pharmaceutique

Also Published As

Publication number Publication date
EP1809612A1 (fr) 2007-07-25
JP2008514551A (ja) 2008-05-08
WO2006034574A1 (fr) 2006-04-06
AU2005289317A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
ZA200703376B (en) Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
PL1954745T3 (pl) Preparat środka zwiększającego przyczepność, sposób jego wytwarzania oraz jego zastosowanie
SI1913001T1 (sl) (r)-n-metilnaltrekson, postopki za njega sintezo in njega farmacevtsko uporabo
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
PL1928882T3 (pl) (S)-N-Metylonaltrekson, sposoby jego syntezy i jego zastosowania farmaceutyczne
IL186090A0 (en) Cgrp antagonists, method for the production thereof, and their use as medicaments
EP1908749A4 (fr) Procede de fabrication d'isocyanate, isocyanate fabrique selon ce procede, et utilisation de cet isocyanate
IL184175A0 (en) Sulfonyl pyrrolidines, method for producing the same and their use as drugs
HK1100409A1 (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
IL181171A0 (en) 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents, etc
IL184526A0 (en) Substituted aminomethylene sulphonamides, production and use thereof as medicaments
IL179170A0 (en) Novel substituted thiophenecarboxamides, their production and their use as medicaments
IL204555A0 (en) (carboxylalkylene-phenyl) phenyl-oxalamides, method for the production thereof, and use of same as a medicatment
IL190460A0 (en) 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
IL184314A0 (en) Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
EP1775649A4 (fr) Système de production
GB0402487D0 (en) Catalytic process
EG25401A (en) Process for the preparation of urea.
PL1783105T3 (pl) Kompozycja zaprawowa, sposób jej wytwarzania i jej zastosowanie
GB0412874D0 (en) Novel pharmaceuticals

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070418

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THALLION PHARMACEUTICALS INC.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MCALPINE, JAMES B.

Inventor name: BANSKOTA, ARJUN H.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090428

17Q First examination report despatched

Effective date: 20090827

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100309